Anna Chang

Anna Chang is the B2B Marketing Lead for the R&D Product Portfolio at Verily, a health technology company under Alphabet. Anna was previously the Director of Corporate Strategy and Market Analysis at Rally Health and held roles at Gilead Sciences, ZS Associates, and The Frankel Group. Anna holds an MBA from Harvard Business School and MS and BS degrees in Biological Sciences from Stanford University.